beta

CMTA

Clementia Pharmaceuticals Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Clementia Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need.

Market Cap: 578 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.clementiapharma.com

Shares Outstanding: 31.7 Million

Float: 31.7 Million

Dividend: 0.0 (0.0%)

Beta: -3.095027

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 401 trading days

From: 2017-12-22 To: 2019-02-22

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud